Figure 3
From: E2F4 regulatory program predicts patient survival prognosis in breast cancer
E2F4 activity predicts patient survival prognosis in an additional seven independent breast cancer datasets. Patients with positive E2F4 scores (red curve) show shorter survival times than those with negative E2F4 scores (green curve) across all datasets (all P values <0.05, log-rank test). Vertical hash marks indicate points of censored data. Survival endpoints are as indicated on the vertical axes: overall survival (OS); relapse-free survival (RFS); distant metastasis-free survival (DMFS).